Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer

Laboratory Investigation; a Journal of Technical Methods and Pathology
Dai ShidaHirokazu Nagawa

Abstract

Lysophosphatidic acid (LPA) is a simple bioactive phospholipid with diverse effects on various cells, that interacts with three G protein-coupled transmembrane receptors, LPA1, LPA2, and LPA3. The expression pattern and functions of these LPA receptors in various tumors have not been fully examined, except in ovarian cancer. To evaluate the LPA receptor expression profile in human colorectal cancer and in normal mucosa, we used real-time reverse transcription-polymerase chain reaction (RT-PCR) and measured the expression levels of LPA1, LPA2, and LPA3 messenger RNA (mRNA) in 26 colorectal cancers and 16 corresponding normal tissue samples. Normal epithelium expressed both LPA1 and LPA2 mRNA at similar levels. In comparison, colorectal cancers expressed LPA1 mRNA at a significantly lower level (0.3-fold; P<0.05), and LPA2 mRNA at a significantly higher level (three-fold; P<0.05), as compared with normal tissues. Thus, the ratio of LPA2/LPA1 increased markedly during malignant transformation (18-fold increase). LPA3 mRNA was expressed at only a low level in both normal and cancer tissues. We also assessed LPA2 expression immunohistochemically using a rat anti-LPA2 monoclonal antibody, and confirmed high expression of LPA2 in colo...Continue Reading

References

Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Jun 2, 1995·The Journal of Biological Chemistry·W H Moolenaar
Dec 1, 1996·Gastroenterology Clinics of North America·R N DuBoisW E Smalley
Sep 5, 1998·JAMA : the Journal of the American Medical Association·Y XuG Casey
Dec 2, 1999·Experimental Cell Research·W H Moolenaar
Feb 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·H LamlumI Tomlinson
May 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E J GoetzlJ K Voice
May 20, 2000·Annals of the New York Academy of Sciences·X FangG B Mills
Nov 23, 2000·Proceedings of the National Academy of Sciences of the United States of America·J J ContosJ Chun
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y ZhengE J Goetzl
Feb 24, 2001·Cellular and Molecular Life Sciences : CMLS·J T Swarthout, H W Walling
Apr 28, 2001·Prostaglandins & Other Lipid Mediators·J R EricksonG B Mills
May 2, 2001·Gynecologic Oncology·B M SchwartzY Xu
Dec 1, 2001·Science·T HlaM J Kluk
Mar 22, 2002·The Lancet Oncology·Andrew M M Haydon, Jeremy R Jass
Jun 19, 2002·JAMA : the Journal of the American Medical Association·Daniel L BakerGabor Tigyi
Jun 19, 2002·Biochimica Et Biophysica Acta·Mei Chuan HuangEdward J Goetzl
Jun 19, 2002·Biochimica Et Biophysica Acta·Xianjun FangGordon B Mills
Oct 2, 2002·The Journal of Biological Chemistry·Junken AokiHiroyuki Arai
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Pao F KueYehia Daaka
Aug 2, 2003·Nature Reviews. Cancer·Gordon B Mills, Wouter H Moolenaar
Dec 4, 2003·Biochemical Society Transactions·O M FischerA Ullrich

❮ Previous
Next ❯

Citations

Jan 24, 2012·Acta Pharmacologica Sinica·Rosamaria Lappano, Marcello Maggiolini
Jun 6, 2012·The Journal of Biological Chemistry·Abir MukherjeeXianjun Fang
Nov 13, 2008·Journal of the National Cancer Institute·Shuangxing YuGordon B Mills
Aug 21, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Songbai LinC Chris Yun
Feb 5, 2011·American Journal of Physiology. Gastrointestinal and Liver Physiology·Citlali Ekaterina Rodriguez PerezJames Yoo
Jan 27, 2011·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Kyoko OkabeToshifumi Tsujiuchi
Jan 25, 2012·Journal of Toxicologic Pathology·Toshifumi TsujiuchiNobuyuki Fukushima
Sep 25, 2009·World Journal of Gastroenterology : WJG·Hong SunBo-Rong Pan
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ming YangSongzhu An
Apr 20, 2014·Mediators of Inflammation·Izabela Wocławek-PotockaDariusz Jan Skarzynski
Jan 16, 2013·Journal of Receptor and Signal Transduction Research·Harini Chowdary VadlamudiJayasri Vulava
Jan 28, 2014·Journal of Receptor and Signal Transduction Research·Toshifumi TsujiuchiNobuyuki Fukushima
Feb 11, 2015·Journal of Periodontology·D Roselyn CerutisTakanari Miyamoto
Jan 8, 2008·Bioorganic & Medicinal Chemistry Letters·Hilary P BeckWang Shen
Jan 2, 2014·Biochemical and Biophysical Research Communications·Yasuhiro SekiAkira Kurisaki
Feb 18, 2005·Journal of Lipid Research·Lygia T Budnik, Bärbel Brunswig-Spickenheier
Feb 13, 2018·Mediators of Inflammation·Silvia Anahi Valdés-Rives, Aliesha González-Arenas
Feb 25, 2005·American Journal of Physiology. Cell Physiology·C Chris YunHyunsuk Shim
Oct 5, 2010·Virchows Archiv : an International Journal of Pathology·Megumu TsujinoToshifumi Tsujiuchi
Jul 6, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rie FukuiToshifumi Tsujiuchi
Jul 26, 2005·The Journal of Pathology·Frédérique Blanchot-JossicJean-François Mosnier
Dec 15, 2005·Journal of Surgical Oncology·Hiroharu YamashitaHirokazu Nagawa
Oct 15, 2005·American Journal of Respiratory Cell and Molecular Biology·Matiur RahamanMarie-Thérèse Walsh
May 15, 2007·American Journal of Physiology. Cell Physiology·Min ChenKathleen L O'Connor
Oct 16, 2007·Expert Reviews in Molecular Medicine·Mandi Murph, Gordon B Mills

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.